0001835654falseQ2December 312023-06-30

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

FORM 6-K

 
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO SECTION 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of August 2023
 
Commission File Number: 001-40310
 
INNOVIZ TECHNOLOGIES LTD.
(Translation of registrant’s name into English)

 
Innoviz Technologies Campus
5 Uri Ariav Street, Bldg. C
Nitzba 300, Rosh HaAin, Israel
 (Address of principal executive offices)

 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F          Form 40-F 
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  
 
 

 
EXPLANATORY NOTE
 
Innoviz Technologies Ltd. (the “Company”) hereby furnishes the following documents as exhibits 99.1 and 99.2:
 
 
 
 
 
This Report on Form 6-K and related exhibits are incorporated by reference into the Company’s registration statements on Form F-3 (File Nos. 333-265170 and 333-267646) and Form S-8 (File Nos.333-255511, 333-265169 and 333-270416), and shall be a part thereof from the date on which this Form 6-K is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.
 
2

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
INNOVIZ TECHNOLOGIES LTD.
 
 
 
Date: August 9, 2023
By:
/s/ Eldar Cegla
 
 
Name: Eldar Cegla
 
 
Title:   Chief Financial Officer
 
 
 
 
3

As part of the Transactions (see Note 1c), the Company assumed a derivative warrants liability related to previously issued private placement warrants in connection with Collective Growth’s initial public offering. The Company utilizes a Black-Scholes option pricing model to estimate the fair value of the private placement warrants which is considered a Level 3 fair value measurement. The warrants are measured at each reporting period, with changes in fair value recognized in financing income, net. Includes revenue from Germany in the amount of $1,500 thousand and $1,926 thousand for the six months ended June 30, 2023 and 2022, respectively. Includes revenues from United States only. 0001835654 2023-01-01 2023-06-30 0001835654 2021-12-31 0001835654us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001835654us-gaap:CommonStockMember 2021-12-31 0001835654 2022-01-01 2022-06-30 0001835654us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001835654us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001835654us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001835654us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001835654us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001835654us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001835654 2022-06-30 0001835654us-gaap:RetainedEarningsMember 2022-06-30 0001835654us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001835654us-gaap:CommonStockMember 2022-06-30 0001835654 2023-06-30 0001835654us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001835654us-gaap:CommonStockMember 2023-06-30 0001835654 2022-12-31 0001835654us-gaap:RetainedEarningsMember 2022-12-31 0001835654us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001835654us-gaap:CommonStockMember 2022-12-31 0001835654us-gaap:RetainedEarningsMember 2021-12-31 0001835654us-gaap:RetainedEarningsMember 2023-06-30 0001835654invz:MarketableSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001835654invz:MarketableSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001835654us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001835654us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001835654us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMemberus-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001835654us-gaap:WarrantMemberus-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001835654us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001835654us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember 2023-01-01 2023-06-30 0001835654us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember 2023-06-30 0001835654invz:MarketableSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001835654us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001835654us-gaap:FairValueInputsLevel2Memberus-gaap:WarrantMemberus-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001835654us-gaap:FairValueInputsLevel1Memberus-gaap:WarrantMemberus-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001835654invz:MarketableSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001835654us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember 2022-12-31 0001835654us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember 2022-01-01 2022-12-31 0001835654invz:MarketableSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001835654invz:MarketableSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001835654invz:MarketableSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001835654invz:MarketableSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001835654us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001835654us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001835654us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001835654us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001835654us-gaap:WarrantMemberus-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001835654us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMemberus-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001835654us-gaap:FairValueInputsLevel2Memberus-gaap:WarrantMemberus-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001835654us-gaap:FairValueInputsLevel1Memberus-gaap:WarrantMemberus-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001835654us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember 2021-12-31 0001835654us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember 2022-06-30 0001835654us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember 2022-01-01 2022-06-30 0001835654 2022-01-01 2022-12-31 0001835654us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001835654us-gaap:RestrictedStockUnitsRSUMember 2023-06-30 0001835654us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-06-30 0001835654us-gaap:CostOfSalesMember 2023-01-01 2023-06-30 0001835654us-gaap:CostOfSalesMember 2022-01-01 2022-06-30 0001835654us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-06-30 0001835654us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-06-30 0001835654us-gaap:SellingAndMarketingExpenseMember 2023-01-01 2023-06-30 0001835654us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-06-30 0001835654us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-06-30 0001835654us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-06-30 0001835654us-gaap:EMEAMember 2022-01-01 2022-06-30 0001835654us-gaap:EMEAMember 2023-01-01 2023-06-30 0001835654srt:AsiaPacificMember 2022-01-01 2022-06-30 0001835654srt:AsiaPacificMember 2023-01-01 2023-06-30 0001835654srt:NorthAmericaMember 2022-01-01 2022-06-30 0001835654srt:NorthAmericaMember 2023-01-01 2023-06-30 0001835654country:DE 2023-01-01 2023-06-30 0001835654country:DE 2022-01-01 2022-06-30 0001835654invz:CustomerTwoMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001835654invz:CustomerOneMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001835654invz:CustomerThreeMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001835654invz:CustomerTwoMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001835654invz:OptionsForPurchaseOfOrdinarySharesMemberus-gaap:WarrantMember 2023-01-01 2023-06-30 0001835654invz:OptionsForPurchaseOfOrdinarySharesMemberinvz:SponsorsEarnoutSharesMember 2023-01-01 2023-06-30 0001835654invz:OptionsForPurchaseOfOrdinarySharesMemberinvz:OptionsAndRsusOutstandingMember 2023-01-01 2023-06-30 0001835654invz:OptionsForPurchaseOfOrdinarySharesMemberus-gaap:WarrantMember 2022-01-01 2022-06-30 0001835654invz:OptionsForPurchaseOfOrdinarySharesMemberinvz:SponsorsEarnoutSharesMember 2022-01-01 2022-06-30 0001835654invz:OptionsForPurchaseOfOrdinarySharesMemberinvz:OptionsAndRsusOutstandingMember 2022-01-01 2022-06-30 xbrli:pure xbrli:shares iso4217:USD iso4217:USDxbrli:shares

 

Exhibit 99.1

 

INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
 

INTERIM CONSOLIDATED FINANCIAL STATEMENTS
 

AS OF JUNE 30, 2023


UNAUDITED
 

INDEX

 

INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
 
INTERIM CONSOLIDATED BALANCE SHEETS (UNAUDITED)

U.S. dollars in thousands (except share and per share data)
 
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
(Unaudited)
       
       ASSETS
           
             
 CURRENT ASSETS:
           
 Cash and cash equivalents
 
$
34,331
   
$
55,718
 
 Short term restricted cash
   
52
     
236
 
 Bank deposits
   
62,710
     
80,684
 
 Marketable securities
   
24,639
     
41,681
 
 Trade receivables, net
   
2,382
     
1,762
 
 Inventory
   
4,584
     
4,236
 
 Prepaid expenses and other current assets
   
2,400
     
3,236
 
Total current assets
   
131,098
     
187,553
 
                 
 LONG-TERM ASSETS:
               
    Marketable securities
   
7,838
     
7,840
 
    Restricted deposits
   
2,508
     
2,543
 
 Property and equipment, net
   
30,744
     
30,489
 
 Operating lease right-of-use assets, net
   
26,528
     
26,927
 
 Other long-term assets
   
83
     
81
 
Total long-term assets
   
67,701
     
67,880
 
                 
Total assets
 
$
198,799
   
$
255,433
 
 
The accompanying notes are an integral part of the interim consolidated financial statements.
 
F - 2

INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
 
INTERIM CONSOLIDATED BALANCE SHEETS (UNAUDITED)

U.S. dollars in thousands (except share and per share data)
 
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
(Unaudited)
       
LIABILITIES AND SHAREHOLDERS' EQUITY
           
             
CURRENT LIABILITIES:
           
 Trade payables
 
$
6,993
   
$
8,367
 
 Advances from customers and deferred revenues
   
4,219
     
4,082
 
 Employees and payroll accruals
   
9,379
     
8,693
 
 Accrued expenses and other current liabilities
   
7,170
     
7,572
 
 Operating lease liabilities
   
5,602
     
3,720
 
Total current liabilities
   
33,363
     
32,434
 
                 
LONG-TERM LIABILITIES:
               
 Advances from customers and deferred revenues
   
121
     
61
 
 Operating lease liabilities
   
28,122
     
30,201
 
 Warrants liability
   
467
     
720
 
Total long-term liabilities
   
28,710
     
30,982
 
                 
SHAREHOLDERS' EQUITY:
               
Ordinary Shares of no-par value: Authorized: 500,000,000 shares as of June 30, 2023 and December 31, 2022; Issued and outstanding: 137,136,395 and 136,185,264 shares as of June 30, 2023 and December 31, 2022, respectively
   
-
     
-
 
 Additional paid-in capital
   
714,534
     
703,851
 
 Accumulated deficit
   
(577,808
)
   
(511,834
)
Total shareholders' equity
   
136,726
     
192,017
 
                 
Total liabilities and shareholders' equity
 
$
198,799
   
$
255,433
 
 
The accompanying notes are an integral part of the interim consolidated financial statements.

 

F - 3

INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
 
INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

U.S. dollars in thousands (except share and per share data)
 
   
Six Months Ended
June 30,
 
   
2023
   
2022
 
   
(Unaudited)
 
             
Revenues
 
$
2,476
   
$
3,571
 
Cost of revenues
   
(9,572
)
   
(6,084
)
                 
Gross loss
   
(7,096
)
   
(2,513
)
                 
Operating expenses:
               
Research and development
   
49,888
     
44,700
 
Sales and marketing
   
4,620
     
5,381
 
General and administrative
   
9,169
     
9,744
 
                 
Total operating expenses
   
63,677
     
59,825
 
                 
Operating loss
   
(70,773
)
   
(62,338
)
                 
Financial income, net
   
5,267
     
4,040
 
                 
Loss before taxes on income
   
(65,506
)
   
(58,298
)
Taxes on income
   
(468
)
   
(48
)
                 
Net loss
 
$
(65,974
)
 
$
(58,346
)
                 
Basic and diluted net loss per ordinary share
 
$
(0.48
)
 
$
(0.43
)
                 
Weighted average number of ordinary shares used in computing basic and diluted net loss per ordinary share
   
136,640,997
     
134,607,839
 
 
The accompanying notes are an integral part of the interim consolidated financial statements.
 
F - 4

INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
 
INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)

U.S. dollars in thousands (except share and per share data)

 

 
Ordinary Shares
   
Additional
Paid-in
Capital
   
Accumulated
Deficit
   
Total
Shareholders’

Equity

 
 
Number
   
Amount
   
                             
Balance as of December 31, 2021
 
134,098,120
   
$
-
   
$
683,764
   
$
 (384,962
)
 
$
298,802
 

Reclassification of warrants liability to equity

  -       -       15       -       15  
Exercise of shares options
 
524,938
     
-
     
311
     
-
     
311
 

Exercise of public warrants

 

100

      -       1       -       1  
Vesting of RSUs
 
648,611
     
-
      -      
-
     
-
 
Share-based compensation
 
-
     
-
     
9,165
     
-
     
9,165
 
Net Loss
 
-
     
-
     
-
     
(58,346
)
   
(58,346
)
                                       
Balance as of June 30, 2022
 
135,271,769
   
$
-
   
$
693,256
   
$
(443,308
)
 
$
249,948
 
                                       
Balance as of December 31, 2022
 
136,185,264
   
$
-
   
$
703,851
   
$
(511,834
)
 
$
192,017
 
Reclassification of warrants liability to equity
 
-
     
-
     
8
     
-
     
8
 
Exercise of shares options
 
289,851
     
-
     
232
     
-
     
232
 
Vesting of RSUs
 
661,280
     
-
     
-
     
-
     
-
 
Share-based compensation
 
-
     
-
     
10,443
     
-
     
10,443
 
Net Loss
 
-
     
-
     
-
     
(65,974
)
   
(65,974
)
 
                                     
Balance as of June 30, 2023
 
137,136,395
   
$
-
   
$
714,534
   
$
 (577,808
)
 
$
136,726
 

 

The accompanying notes are an integral part of the interim consolidated financial statements.

 
F - 5

INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
 
INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

U.S. dollars in thousands (except share and per share data)
 
   
Six Months Ended
June 30,
 
   
2023
   
2022
 
   
(Unaudited)
 
Cash Flows from Operating Activities:
           
             
   Net loss
 
$
(65,974
)
 
$
(58,346
)
                 
   Adjustments required to reconcile net loss to net cash used in Operating Activities:
               
                 
Depreciation and amortization
   
2,954
     
4,192
 
Remeasurement of warrants liability
   
(245
)
   
(789
)
Change in accrued interest on bank deposits
   
455
     
(245
)
Change in marketable securities
   
(237
)
   
707
 
Share-based compensation
   
10,443
     
9,165
 
Foreign exchange loss, net
   
65
     
1,220
 
Change in prepaid expenses and other assets
   
1,014
     
(3,186
)
Change in trade receivables, net
   
(620
)
   
(562
)
Change in inventory
   
(348
)
   
(395
)
Changes in operating lease assets and liabilities, net
   
202
     
(430
)
Change in trade payables
   
(134
)
   
60
 
Change in accrued expenses and other liabilities
   
110
     
(1,185
)
Change in employees and payroll accruals
   
686
     
(558
)
Change in advances from customers and deferred revenues
   
197
     
243
 
                 
Net cash used in operating activities
   
(51,432
)
   
(50,109
)
                 
Cash flows from investing activities:
               
                 
Purchase of property and equipment
   
(5,136
)
   
(5,026
)
Investment in bank deposits
   
(62,000
)
   
(50,000
)
Withdrawal of bank deposits
   
79,500
     
135,000
 
Increase in restricted deposits
   
(40
)
   
(2,580
)
Investment in marketable securities
   
(23,004
)
   
(17,664
)
Proceeds from sales and maturities of marketable securities
   
40,285
     
17,664
 
                 
Net cash provided by investing activities
 
$
29,605
   
$
77,394
 
 
The accompanying notes are an integral part of the interim consolidated financial statements.
 
F - 6

INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
 
INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

U.S. dollars in thousands (except share and per share data)  
 
 
 
Six Months Ended
June 30,
 
   
2023
   
2022
 
   
(Unaudited)
 
Cash flows from financing activities:
           
             
Proceeds from exercise of options
   
227
     
293
 
                 
Net cash provided by financing activities
   
227
     
293
 
                 
Effect of exchange rate changes on cash, cash equivalents and restricted cash
   
29
     
(1,122
)
                 
Increase (decrease) in cash, cash equivalents and restricted cash
   
(21,571
)
   
26,456
 
Cash, cash equivalents and restricted cash at the beginning of the period
   
55,954
     
24,541
 
                 
Cash, cash equivalents and restricted cash at the end of the period
 
$
34,383
   
$
50,997
 
                 
Supplementary disclosure of cash flows activities:
               
                 
(1) Cash paid during the period for:
               
                 
Income taxes
 
$
255
   
$
48
 
                 
(2) Non-cash transactions:
               
                 
Purchase of property and equipment
 
$
564
   
$
7,582
 
Reclassification of warrants liability to equity
  $ 8     $ 15  
Exercise of options
 

$

5    

$

19  
Right-of-use assets recognized with corresponding lease liabilities
 
$
749
   
$
29,267
 
                 
(3) Cash, cash equivalents and restricted cash at the end of the period:
               
                 
Cash and cash equivalents
 
$
34,331
   
$
50,279
 
Short-term restricted cash
    52       718  
                 
   
$
34,383
   
$
50,997
 
 
The accompanying notes are an integral part of the interim consolidated financial statements.
 
F - 7

INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
 
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
U.S. dollars in thousands (except share and per share data)

 

NOTE 1:- GENERAL
 
  a.
Innoviz Technologies Ltd. and its subsidiaries (the “Company” or “Innoviz”) is a Tier-1 direct supplier of high-performance, automotive grade LiDAR sensors and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The Company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger car and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks, as well as other industries that require 3-dimensional high-resolution sensors. In addition, Innoviz’ solutions can enable safe autonomy for other industries, including logistics, drones, robotics, construction and other industrial applications, smart city, smart infrastructures and mapping.
 
  b.
The Company was incorporated on January 18, 2016, under the laws of the state of Israel.
 
  c.
On December 10, 2020, the Company entered into definitive agreements in connection with a merger (the “Transactions”) with Collective Growth Corporation (“Collective Growth”), a special purpose acquisition company, that resulted in Collective Growth becoming a wholly owned subsidiary of the Company upon the consummation of the Transactions on April 5, 2021 (the “Closing Date”).
 
The Company's ordinary shares and warrants were listed on the Nasdaq Stock Market LLC under the trading symbols “INVZ” and “INVZW”, respectively, on April 5, 2021.
 
  d.
As of June 30, 2023, the Company’s principal source of liquidity includes its cash and cash equivalents in the amount of $34,331, bank deposits in the amount of $62,710 and marketable securities in the amount of $32,477, which is sufficient to finance its business plan for at least the next 12 months. As the Company achieves further commercial success, it may need to obtain additional funding to support its continuing operations. If the Company is unable to raise capital when and if needed, it may need to reduce or eliminate some of its research and development programs.

 

NOTE 2:-

SIGNIFICANT ACCOUNTING POLICIES
   
  a.
Interim Financial Statements
 
The accompanying interim consolidated balance sheet as of June 30, 2023, the interim consolidated statements of operations and the interim consolidated statements of cash flows for the six months ended June 30, 2023 and 2022, as well as the interim statement of changes in shareholders’ equity for the six months ended June 30, 2023 and 2022, are unaudited. These unaudited interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission regarding interim financial reporting. In management’s opinion, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for the fair presentation of the Company’s financial position as of June 30, 2023, as well as its results of operations and cash flows for the six months ended June 30, 2023 and 2022. The results of operations for the six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for other interim periods or for future years.
 
  b.
Significant accounting policies
 
The accompanying unaudited interim financial statements should be read in conjunction with the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022 (the “2022 Annual Report”) filed with the Securities and Exchange Commission (the “SEC”) on March 9, 2023.
 
There have been no changes to the significant accounting policies described in the 2022 Annual Report that have had a material impact on the unaudited interim consolidated financial statements and related notes, except as mentioned below (see also Note 2e).

 

F - 8


INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


U.S. dollars in thousands (except share and per share data)

 

NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
   
  c. Use of estimates:
 
The preparation of interim consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the interim consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
 
Significant items subject to such estimates and assumptions include inventory reserves, warranty provision, valuation allowance for deferred tax assets, share-based compensation, fair value of warrants liability and useful lives of property, plant, and equipment. The Company bases these estimates on historical and anticipated results, trends and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.
 
  d.
Concentration of credit risk:
 
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, trade receivables, marketable securities, bank deposits, restricted deposits and restricted cash.
 
Trade receivable of the Company are mainly derived from customers located globally. The Company mitigates its credit risks by performing credit evaluations of its customers’ financial conditions and requires customer advance payments in certain circumstances. The Company generally does not require collateral.
 
The Company invests in marketable securities with an average credit rating of “A” and a maturity of up to three years. The Company’s investment policy is not to invest more than 5% of its investment portfolio in a single security at time of purchase.
 
  e.
Recently adopted accounting pronouncement:
 
On January 1, 2023, the Company adopted ASU No. 2016-13 (Topic 326), Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments, which has replaced the previous incurred loss impairment methodology. Under the new guidance an entity is required to recognize an allowance that reflects its current estimate of credit losses expected to be incurred over the life of the financial instrument based on historical experience, current conditions and reasonable and supportable forecasts. The adoption of ASU 2016-13 did not have a material impact on the interim consolidated financial statements.
 

F - 9


INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


U.S. dollars in thousands (except share and per share data)

 

NOTE 3:-

CONTRACT BALANCES AND REMAINING PERFORMANCE OBLIGATIONS

 
Contract liabilities consisted of the following as of June 30, 2023 and December 31, 2022:
 
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
(Unaudited)
       
Contract liabilities, Current
           
Deferred revenues
 
$
4,151
   
$
4,004
 
Advances from customers
   
68
     
78
 
Total
 
$
4,219
   
$
4,082
 
                 
Contract liabilities, Long-term
               
Deferred revenues
 
$
121
   
$
61
 
Total Contract liabilities
 
$
4,340
   
$
4,143
 
 
During the six months ended June 30, 2023, the Company recognized $42 that was included in deferred revenues balance at December 31, 2022.
 
Remaining Performance Obligation
 
The Company’s remaining performance obligations are comprised of product and engineering services not yet satisfied. As of June 30, 2023, the aggregate amount of the transaction price allocated to remaining performance obligations was $12,536 (out of which, $3,441 is recorded as short-term deferred revenues), which the Company expects to recognize as revenues.
 

F - 10


INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


U.S. dollars in thousands (except share and per share data)

 

NOTE 4:-

FAIR VALUE MEASUREMENTS

 
The below table sets forth the Company’s assets and liabilities that were measured at fair value as of June 30, 2023 and December 31, 2022 by level within the fair value hierarchy.
 
June 30, 2023
 
(Unaudited)
 
 
 
Level 1
   
Level 2
   
Level 3
   
Total
 
Assets:
                       
Marketable securities
 
$
-
   
$
32,477
   
$
-
   
$
32,477
 
 
                               
Total financial assets
 
$
-
   
$
32,477
   
$
-
   
$
32,477
 
                                 
Liabilities:
                               
Warrants (1)
 
$
-
   
$
-
   
$
467
   
$
467
 
                                 
Total financial liabilities
 
$
-
   
$
-
   
$
467
   
$
467
 
 
December 31, 2022
 
 
 
Level 1
   
Level 2
   
Level 3
   
Total
 
Assets:
                       
Marketable securities
 
$
-
   
$
49,521
   
$
-
   
$
49,521
 
 
                               
Total financial assets
 
$
-
   
$
49,521
   
$
-
   
$
49,521
 
                                 
Liabilities:
                               
Warrants (1)
 
$
-
   
$
-
   
$
720
   
$
720
 
                                 
Total financial liabilities
 
$
-
   
$
-
   
$
720
   
$
720
 
 
During the six months ended June 30, 2023, the Company recognized net trading gain of $237 which relates to marketable securities held by the Company.
 
  (1)
As part of the Transactions (see Note 1c), the Company assumed a derivative warrants liability related to previously issued private placement warrants in connection with Collective Growth’s initial public offering. The Company utilizes a Black-Scholes option pricing model to estimate the fair value of the private placement warrants which is considered a Level 3 fair value measurement. The warrants are measured at each reporting period, with changes in fair value recognized in financing income, net.
 

F - 11


INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


U.S. dollars in thousands (except share and per share data)

 

NOTE 4:-

FAIR VALUE MEASUREMENTS (Cont.)

   
The change in the fair value of the derivative private warrants liability is summarized as follows:
 
   
Six Months Ended June 30,
 
   
2023
   
2022
 
   
(Unaudited)
 
Balance as of January 1
 
$
720
   
$
1,639
 
Change in fair value of warrants liability
   
(245
)
   
(789
)
Reclassification of warrants liability to equity
   
(8
)
   
(15
)
Balance as of June 30
 
$
467
   
$
835
 
 
The estimated fair value of the private placement warrant derivative liabilities is determined using Level 3 inputs. Inherent in a Black-Scholes option pricing model are assumptions related to expected share price volatility, expiration, risk-free interest rate and dividend yield. The Company estimates the volatility of its private warrants based on implied volatility of the publicly traded warrants and the historical volatility of the company’s share price and of a selected peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve as of the valuation date for a maturity similar to the expiration of the warrants. The dividend yield is based on the historical rate, which the Company anticipates remaining at zero. The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:
 
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
(Unaudited)
       
Fair value determined per warrant
 
$
1.03
   
$
1.57
 
Expected volatility
   
105
%
   
92.5
%
Expected annual dividend yield
   
0
%
   
0
%
Expected term (years)
   
2.8
     
3.3
 
Risk-free rate
   
4.6
%
   
4.2
%

 

NOTE 5:-

LEASES

 
Below is a summary of the Company operating right-of-use assets, net and operating lease liabilities as of June 30, 2023:
 
Operating lease right-of-use assets, net
 
$
26,528
 
 
       
Operating lease liabilities, current
 
$
5,602
 
Operating lease liabilities, non-current
   
28,122
 
 
       
Total operating lease liabilities
 
$
33,724
 
Weighted average remaining lease term (years)
   
9.37
 
Weighted average discount rate of operating leases
   
4.59
%

 

F - 12


INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


U.S. dollars in thousands (except share and per share data)

 

NOTE 5:-

LEASES (Cont.)

   
Additional information regarding the Company’s operating leases:
 
   
Six Months Ended
June 30, 2023
(unaudited)
 
Operating lease costs
 
$
1,894
 
Variable lease payments
 
$
118
 
Short term lease costs
 
$
6
 
Operating cash flows from lease incentives received, net of cash paid for operating leases
 
$
184
 
 
Minimum lease payments over the remaining lease periods as of June 30, 2023, are as follows:
 
Year Ended December 31, (unaudited)
     
2023
 
$
1,997
 
2024
   
3,876
 
2025
   
4,204
 
2026
   
4,207
 
2027
   
4,197
 
Thereafter
   
20,750
 
 
       
Total undiscounted lease payments
 
$
39,231
 
 
       
Less: interest
   
(5,507
)
 
       
Present value of lease liabilities
 
$
33,724
 

 

NOTE 6:-
COMMITMENTS AND CONTINGENCIES
 
Legal proceedings:
 
The Company is currently not part, as plaintiff or defendant, to any legal proceedings that, individually or in the aggregate, are expected by the Company to have a material effect on the Company's business, financial position, results of operations or cash flows. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss. These accruals are reviewed at least yearly and adjusted to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a matter.

 

F - 13


INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


U.S. dollars in thousands (except share and per share data)

 

NOTE 7:-
SHARE-BASED COMPENSATION
 
  a.
Options granted:
 
A summary of option balances as of June 30, 2023 (unaudited), and changes during the six months then ended are as follows:
 
   
Number of options
   
Weighted-average exercise price
   
Weighted- average
remaining contractual term 
(in years)
   
Aggregate intrinsic value
 
                         
Outstanding as of December 31, 2022
   
14,080,996
   
$
5.24
     
6.00
   
$
19,724
 
                                 
Granted
   
11,784
    $
4.75
             
-
 
Exercised
   
(289,851
)
  $
0.80
            $
786
 
Forfeited
   
(191,460
)
  $
5.36
            $
114
 
Expired
   
(67,235
)
  $
7.66
             
-
 
                                 
Outstanding as of June 30, 2023
   
13,544,234
   
$
5.33
     
5.45
   
$
12,079
 
                                 
Exercisable as of June 30, 2023
   
9,954,056
   
$
5.20
     
5.33
   
$
10,692
 
 
  b.
RSUs granted:
 
A summary of RSUs activity for the six months ended June 30, 2023 (unaudited), is as follows:
 
   
Number of
shares
   
Weighted
average grant date fair value
per share
 
             
Unvested as of December 31, 2022
   
7,308,579
   
$
5.95
 
Granted
   
960,622
   

$

4.06
 
Vested
   
(661,280
)
 

$

5.99
 
Forfeited
   
(285,596
)
 

$

5.43
 
Unvested as of June 30, 2023
   
7,322,325
   
$
5.72
 

 

F - 14


INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


U.S. dollars in thousands (except share and per share data)

 

NOTE 7:-
SHARE-BASED COMPENSATION (Cont.)
 
  c.
Share-based compensation expenses:
 
The total share-based compensation expenses related to all of the Company’s equity-based awards, which include options and RSUs recognized in the Company’s consolidated statements of operations for the six months ended June 30, 2023, and 2022, are as follows:
 
   
Six Months Ended June 30,
 
   
2023
   
2022
 
   
(Unaudited)
 
Cost of revenues
 
$
181
   
$
76
 
Research and development
   
6,926
     
5,380
 
Sales and marketing
   
682
     
1,367
 
General and administrative
   
2,654
     
2,342
 
   
$
10,443
   
$
9,165
 
 
As of June 30, 2023, unrecognized compensation cost related to share options and RSUs was $42,363, which is expected to be recognized over a weighted average period of 2.55 years.

 

NOTE 8:-
BASIC AND DILUTED NET LOSS PER SHARE
 
The following table sets forth the computation of the net loss per share for the period presented:
 
   
Six Months Ended June 30,
 
   
2023
   
2022
 
   
(Unaudited)
 
             
Numerator:
           
             
Net Loss
 
$
(65,974
)
 
$
(58,346
)
                 
Denominator:
               
 
               
     
136,640,997
     
134,607,839
 
 
The following potential ordinary shares have been excluded from the calculation of diluted net loss per share for the period presented due to their anti-dilutive effect:
 
  a.
16,231,141 warrants, 2,402,178 sponsors earnout shares, 20,866,559 outstanding options to purchase Ordinary Shares and unvested RSUs as of June 30, 2023.
 
  b.
16,231,141 warrants, 2,402,178 sponsors earnout shares, 20,096,766 outstanding options to purchase Ordinary Shares and unvested RSUs as of June 30, 2022.

 

F - 15


INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


U.S. dollars in thousands (except share and per share data)

 

NOTE 9:-

GEOGRAPHIC AND CUSTOMER INFORMATION

 

  a.
Geographic information:
 
Following is a summary of revenues by geographic areas. Revenues attributed to geographic areas, based on the location where the customers accept delivery of the products and services:
 
   
Six Months Ended June 30,
 
   
2023
   
2022
 
   
(Unaudited)
 
             
Europe, Middle East and Africa (*)
 
$
1,640
   
$
2,000
 
Asia Pacific
   
260
     
334
 
North America (**)
   
576
     
1,237
 
                 
   
$
2,476
   
$
3,571
 
 
  (*)
Includes revenue from Germany in the amount of $1,500 thousand and $1,926 thousand for the six months ended June 30, 2023 and 2022, respectively.
 
  (**)
Includes revenues from United States only.
 
  b.
Customers accounted for over 10% of revenue:
 
As of June 30, 2023, Customer A, B and C accounted for 41%, 23%, 16% of revenues, respectively.
 
As of June 30, 2022, Customer B accounted for 81% of revenues.

 

F - 16



Exhibit 99.2

OPERATING AND FINANCIAL REVIEW AND PROSPECTS

You should read the following discussion and analysis of our financial condition and results of operations together with (i) our unaudited interim consolidated financial statements as of and for the six months ended June 30, 2023, included as Exhibit 99.1 to this Report on Form 6-K (this “Report”), (ii) our audited consolidated financial statements and other financial information as of and for the year ended December 31, 2022 appearing in our Annual Report on Form 20-F for the year ended December 31, 2022 (our “Annual Report”) and (iii) Item 5 — “Operating and Financial Review and Prospects” of our Annual Report.  Some of the information contained in this discussion and analysis, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in the section entitled “Cautionary Statement Regarding Forward-Looking Statement” and in the section entitled Item 3.D. “Risk Factors” of our Annual Report, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.

Unless otherwise designated, the terms “we”, “us”, “our”, “Innoviz”, “the Company” and “our company” refer to Innoviz Technologies Ltd.

Forward-Looking Statements

Statements in this Report may constitute “forward-looking statements” within the meaning of the United States federal securities laws. These forward-looking statements can generally be identified as such because the context of the statement will include words such as “may,” “might,” “will,” “could,” “would,” “intends,” “plans,” “believes,” “anticipates,” “expects,” “seeks,” “estimates,” “predicts,” “potential,” “continue,” “contemplate” or “opportunity,” the negative of these words or words of similar import. Similarly, statements that describe our business outlook or future economic performance, anticipated revenues, expenses or other financial items, introductions and advancements in development of products, and plans and objectives related thereto, and statements concerning assumptions made or expectations as to any future events, conditions, performance or other matters, are also forward-looking statements. Forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those stated in such statements. Factors that could cause or contribute to such differences include, but are not limited to, those set forth in Item 3.D. “Risk Factors” in our Annual Report, as well as those discussed elsewhere in our Annual Report and in our other filings with the Securities and Exchange Commission.
 
Company Overview

We are a Tier-1 direct supplier of high-performance, automotive grade LiDAR sensors and perception software that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. We believe that we provide a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger car and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks, as well as other industries that require 3-dimensional high-resolution sensors. In addition, our solutions can enable safe autonomy for other industries, including logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructures, security and mapping.

In 2022, following more than two years of extensive diligence and qualification, we were selected by Volkswagen as its direct LiDAR supplier for automated vehicles within the Volkswagen brands with our InnovizTwo next generation high-performance automotive-grade LiDAR sensor. Later in 2022, an Asia-based automotive OEM selected us to serve as its direct LiDAR supplier for series production passenger vehicles. For further updates, please see Recent Developments below.

The sustained cooperation with our customers provides our engineers and other research and development personnel with a valuable competitive edge. These engineers and other research and development personnel have been meticulously trained to design, operate and verify our many ground-breaking innovations in accordance and in compliance with the rigorous ISO26262 standard for Functional Safety in the automotive industry. Compliance with this and other standards have been enforced by regular ongoing audits of Innoviz and rigorous testing by our key suppliers, existing customers and prospective customers that thoroughly review the performance of various elements of our operations. As a result, our products have been constructed from the bottom up with hardware and software technology that meets the most stringent automotive safety, quality, environmental, manufacturing, and other standards.


Our innovation has produced LiDAR solutions that deliver market leading performance and that meet the current demanding safety requirements for Level 2+ through Level 5 autonomous vehicles at price points suitable for mass produced passenger vehicles. Our integrated custom design of advanced hardware and software components, which leverages the multidisciplinary expertise and experience of our team, enables us to provide turn-key autonomous solutions that are likely to accelerate widespread adoption across automakers at serial production scale.

Our robust software suite enables our ~905nm wavelength laser-based LiDAR architecture to be easily leveraged to provide compelling solutions for Level 2+ through Level 5. We believe this means that we are positioned to penetrate the current market, which is currently characterized mainly by Level 2+ production, and to continue to capture and extend our market share to Level 3 and above, as the market continues to mature.

We are currently expanding our third-party manufacturing capacity through contract manufacturers to meet an anticipated increase in customer demand for our products, while also further developing a next generation high-performance automotive-grade LiDAR sensor, the InnovizTwo, that is expected to provide further cost efficiencies, while enabling even higher performance solutions for vehicles offering driving automation levels of Level 2+ and above.

In addition, during 2022 Innoviz became a Tier-1 supplier to the automotive industry. This allows Innoviz to have direct technical discussions with end-customers and to improve pricing to automotive OEMs with the goal of strengthening our position in the automotive market. This has already played a significant role in two of our major OEM program wins, one in Europe and one in Asia.

Recent Developments

In 2023, we announced that a leading global automotive customer aims to expand its use of our InnovizTwo LiDAR to its existing light commercial vehicle program. In addition, on August 2, 2023 we announced together with BMW Group that we are expanding our collaboration by starting a B-sample development phase on a new generation of LiDAR. Under the new development agreement, following BMW requirements, we will develop these B-samples based on our second generation InnovizTwo LiDAR sensor.
 
A. Results of Operations

The results of operations presented below should be reviewed together with our unaudited interim consolidated financial statements as of and for the six months ended June 30, 2023, included in Exhibit 99.1 to this Report, our audited consolidated financial statements as of and for the year ended December 31, 2022 appearing in our Annual Report , and (iii) Item 5 - “Operating and Financial Review and Prospects” of our Annual Report.

2

The following table sets forth our consolidated results of operations data for the periods presented:

   
Six Months Ended
June 30,
 
   
2023
   
2022
 
   
(In thousands except per share data)
(unaudited)
 
Revenues          
 
$
2,476
   
$
3,571
 
Cost of revenues          
   
(9,572
)
   
(6,084
)
Gross loss          
   
(7,096
)
   
(2,513
)
Operating expenses:
               
Research and development          
   
49,888
     
44,700
 
Sales and marketing          
   
4,620
     
5,381
 
General and administrative          
   
9,169
     
9,744
 
Total operating expenses          
   
63,677
     
59,825
 
Operating loss          
   
(70,773
)
   
(62,338
)
Financial income, net          
   
5,267
     
4,040
 
Loss before taxes on income          
   
(65,506
)
   
(58,298
)
Taxes on income          
   
(468
)
   
(48
)
Net loss          
 
$
(65,974
)
 
$
(58,346
)
Basic and diluted net loss per ordinary share          
 
$
(0.48
)
 
$
(0.43
)
Weighted average number of ordinary shares used in computing basic and diluted net loss per ordinary share
   
136,640,997
     
134,607,839
 

3

 
Comparison of the Six Months Ended June 30, 2023 and 2022
 
Revenues
 
   
Six Months Ended June 30,
   
Change
   
Change
 
   
2023
   
2022
   
$
   
%
 
   
(In thousands)
   
(In thousands
   
(In thousands)
       
Revenues          
 
$
2,476
   
$
3,571
   
$
(1,095
)
   
(31
)%
 
Revenues decreased by approximately $1.1 million, or 31%, to approximately $2.5 million for the six months ended June 30, 2023, from approximately $3.6 million for the six months ended June 30, 2022.
 
The decrease in revenues was primarily due to progress in the BMW program as it transitioned to volume production at Magna, the Tier-1 supplier of the program. The transition includes a shift from selling full LiDAR units to selling components to Magna at lower production average sales prices. The decline of BMW program revenues was partially offset by growth in the volume of unit sales.
 
Cost of Revenues and Gross Margin
 
   
Six Months Ended June 30,
   
Change
   
Change
 
   
2023
   
2022
   
$
   
%
 
   
(In Thousands except percentages)
   
(In thousands)
       
Cost of revenues          
 
$
9,572
   
$
6,084
   
$
3,488
     
57
%
Gross margin          
   
(287
)%
   
(70
)%
               
 
Cost of revenues increased by approximately $3.5 million, or 57%, to approximately $9.6 million for the six months ended June 30, 2023, from approximately $6.1 million for the six months ended June 30, 2022.
 
The increase in cost of revenues was primarily due to full realization of the production inefficiencies of InnovizOne and related production salary cost. Gross margin decreased to approximately (287)% for the six months ended June 30, 2023, from approximately (70)% for the six months ended June 30, 2022, primarily due to the same factors that resulted in the increase in cost of revenues.
 
Operating Expenses
 
   
Six Months Ended June 30,
   
Change
   
Change
 
   
2023
   
2022
   
$
   
%
 
   
(In Thousands)
   
(In Thousands)
   
(In Thousands)
       
Research and development         
  $
49,888
    $
44,700
    $
5,188
   
12 %
Sales and marketing          
   
4,620
     
5,381
     
(761
)
   
(14
)%
General and administrative          
   
9,169
     
9,744
     
(575
)
   
(6
)%
Total operating expenses          
 
$
63,677
   
$
59,825
   
$
3,852
     
6
%
 
Research and Development
 
Research and development expenses increased by approximately $5.2 million, or 12%, to approximately $49.9 million for the six months ended June 30, 2023, from approximately $44.7 million for the six months ended June 30, 2022.
 
The increase was primarily attributable to an increase in headcount due to the recruitment of additional engineers to develop the InnovizTwo product, leading to higher personnel expenses and share-based compensation.
 
4

Sales and Marketing
 
Sales and marketing expenses decreased by approximately $0.8 million, or 14%, to approximately $4.6 million for the six months ended June 30, 2023, from approximately $5.4 million for the six months ended June 30, 2022.
 
The decrease was primarily attributable to a decrease in share-based compensation.
 
General and Administrative
 
General and administrative expenses decreased by approximately $0.5 million, or 6%, to approximately $9.2 million for the six months ended June 30, 2023, from approximately $9.7 million for the six months ended June 30, 2022.
 
The decrease was primarily attributable to a decrease in depreciation and amortization, partly offset by an increase in payroll and share-based compensation.
 
Financial Income , net
 
   
Six Months Ended June 30
   
Change
   
Change
 
   
2023
   
2022
   
$
   
%
 
   
(In Thousands)
   
(In Thousands)
   
(In Thousands)
       
Financial income, net          
 
$
5,267
   
$
4,040
   
$
1,227
     
30
%
 
Financial income, net was approximately $5.3 million for the six months ended June 30, 2023, compared to financial income, net of approximately $4.0 million for the six months ended June 30, 2022.
 
The increase was primarily related to gain related to marketable securities of $1.7 million and to bank deposit interest income of $1.5 million. These were partially offset by a decrease in income from exchange rate differences arising from our ILS denominated lease liabilities under ASC 842 of $1.7 million and by a decrease of income related to warrants liability revaluation in the amount of $0.5 million.
 
Quantitative and Qualitative Disclosures About Market Risk
 
We are exposed to a variety of risks, including foreign currency exchange fluctuations, changes in interest rates and inflation. We regularly assess currency, interest rate and inflation risks to minimize any adverse effects on our business as a result of those factors.
 
Foreign Currency Risk
 
Our financial results are reported in USD, and changes in the exchange rate between USD and local currencies in the countries in which we operate (primarily ILS) may affect the results of our operations. In the six months ended June 30, 2023, approximately 84% of our revenues were denominated in USD. The USD cost of our operations in countries other than the United States may be negatively influenced by devaluation of the USD against other currencies.
 
During the six months ended June 30, 2023, the value of the USD appreciated against the value of the ILS by approximately 5.1%. Our most significant foreign currency exposures are related to our operations in Israel. The Company hedges its anticipated exposure by exchanging USD into ILS in amounts sufficient to fund up to three months of operations and monitoring foreign currency exchange rates over time.
 
Interest Rate Risk
 
Our investment strategy is to achieve a return that will allow us to preserve capital and meet our liquidity requirements. We invest in bank deposits and marketable securities, primarily in USD.
 
Our cash and cash equivalents are exposed to market risk related to changes in interest rates, which is affected by changes in the general level of the Bank of Israel interest rates and United States Federal Reserve interest rates. Due to the short-term nature and the low-risk profile of our interest-bearing accounts, an immediate 10% change in interest rates would not have a material effect on the fair market value of our cash and cash equivalents, bank deposits and restricted bank deposits or on our financial position or results of operations.
 
5

Our investments in marketable securities are primarily in securities with an average credit rating of “A” and a maturity of up to three years. We do not intend to invest more than 5% of our investment portfolio in a single security at time of purchase.
 
Other Market Risks
 
We do not believe that inflation had a material effect on our business, financial conditions or results of operations during the six months ended June 30, 2023 and 2022.
 
B. Liquidity and Capital Resources
 
Sources of Liquidity
 
During the six months ended June 30, 2023 and 2022, we funded our operations primarily from approximately $370 million in proceeds we received from the Business Combination we completed in April 2021 and, to a lesser extent, from revenues generated from the sale of goods and services. As of June 30, 2023, we had approximately $129.6 million in cash and cash equivalents, short term deposits, marketable securities and short term restricted cash. Cash equivalents and marketable securities are invested in accordance with our investment policy.
 
Cash Flow Summary
 
The following table summarizes our cash flows for the periods presented:
 
   
Six Months Ended June 30,
 
   
2023
   
2022
 
   
(In Thousands)
   
(In Thousands)
 
Net cash used in operating activities          
 
$
(51,432
)
 
$
(50,109
)
Net cash provided by investing activities          
   
29,605
     
77,394
 
Net cash provided by financing activities          
   
227
     
293
 
Effect of exchange rate changes on cash, cash equivalents and restricted cash
   
29
     
(1,122
)
Net increase (decrease) in cash, cash equivalents and restricted cash
 
$
(21,571
)
 
$
26,456
 
 
Operating Activities
 
During the six months ended June 30, 2023, operating activities used approximately $51.4 million. The primary factors affecting operating cash flows during the six months ended June 30, 2023 were the net loss of approximately $66.0 million, impacted by non-cash charges of approximately $14.6 million consisting of stock-based compensation of approximately $10.4 million, depreciation and amortization of approximately $3.0 million and a decrease in working capital of approximately $1.2 million.
 
During the six months ended June 30, 2022, operating activities used approximately $50.1 million. The primary factors affecting operating cash flows during the six months ended June 30, 2022 were the net loss of approximately $58.3 million, impacted by non-cash charges of approximately $8.2 million consisting of stock-based compensation of approximately $9.2 million, depreciation and amortization of approximately $4.2 million, partially offset by an increase in working capital of approximately $5.2 million.
 
Investing Activities
 
During the six months ended June 30, 2023, cash provided by investing activities was approximately $29.6 million, which primarily resulted from withdrawal of bank deposits of approximately $79.5 million and net proceeds from sales and maturities of marketable securities of approximately $17.3 million, partially offset by investment in bank deposits of approximately $62.0 million and purchase of property and equipment of approximately $5.1 million.
 
During the six months ended June 30, 2022, cash provided by investing activities was approximately $77.4 million, which was primarily from withdrawal of bank deposits of approximately $135.0 million, partially offset by investment in bank deposits of approximately $50.0 million, purchase of property and equipment of approximately $5.0 million and an increase in restricted deposits of approximately $2.6 million.
 
6

Financing Activities
 
During the six months ended June 30, 2023, cash provided by financing activities was approximately $0.2 million resulting from the exercise of employee stock options.
 
During the six months ended June 30, 2022, cash provided by financing activities was approximately $0.3 million resulting from the exercise of employee stock options.
 
Funding Requirements
 
Our expense structure is stable, our expenses may gradually increase in connection with our ongoing activities. As we achieve further commercial success, we may need to obtain additional funding to support our continuing operations. In addition, our financial stability is reviewed by existing and potential customers from time to time and a stronger cash position may be perceived positively by such customers and may also provide us with higher grading in such customers’ diligence processes. If we are unable to raise capital when and if needed, we could be forced to delay, reduce or eliminate some of our research and development programs or future commercialization efforts.
 
As of June 30, 2023, we had cash and cash equivalents, short term bank deposits, short term restricted cash and marketable securities of approximately $129.6 million. We expect those funds to be sufficient to continue to execute our business plan for at least the next 12 months.
 
We also expect our losses to be higher in future periods as we:
 

expand production capabilities to produce our LiDAR solutions, and accordingly incur costs associated with outsourcing the production of our LiDAR solutions;

expand our design, development, installation and servicing capabilities;

increase our investment in research and development;

increase our test and validation activities as part of our Tier 1 responsibilities;

produce an inventory of our LiDAR solutions; and

increase our sales and marketing activities and develop our distribution infrastructure.
 
Because we will incur costs and expenses from these efforts before we receive incremental revenues with respect thereto, losses in future periods will be significant. In addition, we may find that these efforts are more expensive than we currently anticipate or that these efforts may not result in revenues, which would further increase our losses.
 
Off-Balance Sheet Arrangements
 
The Company’s remaining performance obligations are comprised of product and engineering services not yet satisfied. As of June 30, 2023, the aggregate amount of the transaction price allocated to remaining performance obligations was $9.1 million, which we expect to recognize as revenue in future years.
 
Other than as set forth above, we have not entered into any off-balance sheet arrangements and do not have any holdings in variable interest entities.

7




v3.23.2
Cover Page
6 Months Ended
Jun. 30, 2023
Cover [Abstract]  
Entity Registrant Name INNOVIZ TECHNOLOGIES LTD.
Entity Central Index Key 0001835654
Document Type 6-K
Amendment Flag false
Document Period End Date Jun. 30, 2023
Document Fiscal Period Focus Q2
Current Fiscal Year End Date --12-31
Document Fiscal Year Focus 2023
Entity File Number 001-40310
Entity Address, Address Line One Innoviz Technologies Campus
Entity Address, Address Line Two 5 Uri Ariav Street, Bldg. C
Entity Address, Address Line Three Nitzba 300
Entity Address, City or Town Rosh HaAin
Entity Address, Country IL
v3.23.2
INTERIM CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
CURRENT ASSETS:    
Cash and cash equivalents $ 34,331 $ 55,718
Short term restricted cash 52 236
Bank deposits 62,710 80,684
Marketable securities 24,639 41,681
Trade receivables, net 2,382 1,762
Inventory 4,584 4,236
Prepaid expenses and other current assets 2,400 3,236
Total current assets 131,098 187,553
LONG-TERM ASSETS:    
Marketable securities 7,838 7,840
Restricted deposits 2,508 2,543
Property and equipment, net 30,744 30,489
Operating lease right-of-use assets, net 26,528 26,927
Other long-term assets 83 81
Total long-term assets 67,701 67,880
Total assets 198,799 255,433
CURRENT LIABILITIES:    
Trade payables 6,993 8,367
Advances from customers and deferred revenues 4,219 4,082
Employees and payroll accruals 9,379 8,693
Accrued expenses and other current liabilities 7,170 7,572
Operating lease liabilities 5,602 3,720
Total current liabilities 33,363 32,434
LONG-TERM LIABILITIES:    
Advances from customers and deferred revenues 121 61
Operating lease liabilities 28,122 30,201
Warrants liability 467 720
Total long-term liabilities 28,710 30,982
SHAREHOLDERS' EQUITY:    
Ordinary Shares of no-par value: Authorized: 500,000,000 shares as of June 30, 2023 and December 31, 2022; Issued and outstanding: 137,136,395 and 136,185,264 shares as of June 30, 2023 and December 31, 2022, respectively 0 0
Additional paid-in capital 714,534 703,851
Accumulated deficit (577,808) (511,834)
Total shareholders' equity 136,726 192,017
Total liabilities and shareholders' equity $ 198,799 $ 255,433
v3.23.2
INTERIM CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares
Jun. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Common stock shares no par value $ 0 $ 0
Common stock shares authorized 500,000,000 500,000,000
Common stock shares outstanding 137,136,395 136,185,264
Common stock shares issued 137,136,395 136,185,264
v3.23.2
INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]    
Revenues $ 2,476 $ 3,571
Cost of revenues (9,572) (6,084)
Gross loss (7,096) (2,513)
Operating expenses:    
Research and development 49,888 44,700
Sales and marketing 4,620 5,381
General and administrative 9,169 9,744
Total operating expenses 63,677 59,825
Operating loss (70,773) (62,338)
Financial income, net 5,267 4,040
Loss before taxes on income (65,506) (58,298)
Taxes on income (468) (48)
Net loss $ (65,974) $ (58,346)
Basic net loss per ordinary share $ (0.48) $ (0.43)
Diluted net loss per ordinary share $ (0.48) $ (0.43)
Weighted average number of ordinary shares used in computing basic net loss per ordinary share 136,640,997 134,607,839
Weighted average number of ordinary shares used in computing diluted net loss per ordinary share 136,640,997 134,607,839
v3.23.2
INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Ordinary Shares [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Beginning balance at Dec. 31, 2021 $ 0 $ 683,764 $ (384,962) $ 298,802
Beginning balance (Shares) at Dec. 31, 2021 134,098,120      
Reclassification of warrants liability to equity $ 0 15 0 15
Exercise of shares options $ 0 311 0 311
Exercise of shares options (Shares) 524,938      
Exercise of public warrants $ 0 1 0 1
Exercise of public warrants (Shares) 100      
Vesting of RSUs $ 0 0 0 0
Vesting of RSUs (shares) 648,611      
Share-based compensation $ 0 9,165 0 9,165
Net Loss 0 0 (58,346) (58,346)
Ending balance at Jun. 30, 2022 $ 0 693,256 (443,308) 249,948
Ending balance (Shares) at Jun. 30, 2022 135,271,769      
Beginning balance at Dec. 31, 2022 $ 0 703,851 (511,834) 192,017
Beginning balance (Shares) at Dec. 31, 2022 136,185,264      
Reclassification of warrants liability to equity $ 0 8 0 8
Exercise of shares options $ 0 232 0 $ 232
Exercise of shares options (Shares) 289,851     289,851
Vesting of RSUs $ 0 0 0 $ 0
Vesting of RSUs (shares) 661,280      
Share-based compensation $ 0 10,443 0 10,443
Net Loss 0 0 (65,974) (65,974)
Ending balance at Jun. 30, 2023 $ 0 $ 714,534 $ (577,808) $ 136,726
Ending balance (Shares) at Jun. 30, 2023 137,136,395      
v3.23.2
INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash Flows from Operating Activities:    
Net loss $ (65,974) $ (58,346)
Adjustments required to reconcile net loss to net cash used in Operating Activities:    
Depreciation and amortization 2,954 4,192
Remeasurement of warrants liability (245) (789)
Change in accrued interest on bank deposits 455 (245)
Change in marketable securities (237) 707
Share-based compensation 10,443 9,165
Foreign exchange loss, net 65 1,220
Change in prepaid expenses and other assets 1,014 (3,186)
Change in trade receivables, net (620) (562)
Change in inventory (348) (395)
Changes in operating lease assets and liabilities, net 202 (430)
Change in trade payables (134) 60
Change in accrued expenses and other liabilities 110 (1,185)
Change in employees and payroll accruals 686 (558)
Change in advances from customers and deferred revenues 197 243
Net cash used in operating activities (51,432) (50,109)
Cash flows from investing activities:    
Purchase of property and equipment (5,136) (5,026)
Investment in bank deposits (62,000) (50,000)
Withdrawal of bank deposits 79,500 135,000
Increase in restricted deposits (40) (2,580)
Investment in marketable securities (23,004) (17,664)
Proceeds from sales and maturities of marketable securities 40,285 17,664
Net cash provided by investing activities 29,605 77,394
Cash flows from financing activities:    
Proceeds from exercise of options 227 293
Net cash provided by financing activities 227 293
Effect of exchange rate changes on cash, cash equivalents and restricted cash 29 (1,122)
Increase (decrease) in cash, cash equivalents and restricted cash (21,571) 26,456
Cash, cash equivalents and restricted cash at the beginning of the period 55,954 24,541
Cash, cash equivalents and restricted cash at the end of the period 34,383 50,997
Cash paid during the period for:    
Income taxes 255 48
Non-cash transactions:    
Purchase of property and equipment 564 7,582
Reclassification of warrants liability to equity 8 15
Exercise of options 5 19
Right-of-use assets recognized with corresponding lease liabilities 749 29,267
Cash, cash equivalents and restricted cash at the end of the period:    
Cash and cash equivalents 34,331 50,279
Short-term restricted cash 52 718
Cash, cash equivalents and restricted cash at end of the year $ 34,383 $ 50,997
v3.23.2
GENERAL
6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GENERAL
NOTE 1:- GENERAL
 
  a.
Innoviz Technologies Ltd. and its subsidiaries (the “Company” or “Innoviz”) is a Tier-1 direct supplier of high-performance, automotive grade LiDAR sensors and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The Company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger car and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks, as well as other industries that require 3-dimensional high-resolution sensors. In addition, Innoviz’ solutions can enable safe autonomy for other industries, including logistics, drones, robotics, construction and other industrial applications, smart city, smart infrastructures and mapping.
 
  b.
The Company was incorporated on January 18, 2016, under the laws of the state of Israel.
 
  c.
On December 10, 2020, the Company entered into definitive agreements in connection with a merger (the “Transactions”) with Collective Growth Corporation (“Collective Growth”), a special purpose acquisition company, that resulted in Collective Growth becoming a wholly owned subsidiary of the Company upon the consummation of the Transactions on April 5, 2021 (the “Closing Date”).
 
The Company's ordinary shares and warrants were listed on the Nasdaq Stock Market LLC under the trading symbols “INVZ” and “INVZW”, respectively, on April 5, 2021.
 
  d.
As of June 30, 2023, the Company’s principal source of liquidity includes its cash and cash equivalents in the amount of $34,331, bank deposits in the amount of $62,710 and marketable securities in the amount of $32,477, which is sufficient to finance its business plan for at least the next 12 months. As the Company achieves further commercial success, it may need to obtain additional funding to support its continuing operations. If the Company is unable to raise capital when and if needed, it may need to reduce or eliminate some of its research and development programs.
v3.23.2
SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
SIGNIFICANT ACCOUNTING POLICIES

NOTE 2:-

SIGNIFICANT ACCOUNTING POLICIES
   
  a.
Interim Financial Statements
 
The accompanying interim consolidated balance sheet as of June 30, 2023, the interim consolidated statements of operations and the interim consolidated statements of cash flows for the six months ended June 30, 2023 and 2022, as well as the interim statement of changes in shareholders’ equity for the six months ended June 30, 2023 and 2022, are unaudited. These unaudited interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission regarding interim financial reporting. In management’s opinion, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for the fair presentation of the Company’s financial position as of June 30, 2023, as well as its results of operations and cash flows for the six months ended June 30, 2023 and 2022. The results of operations for the six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for other interim periods or for future years.
 
  b.
Significant accounting policies
 
The accompanying unaudited interim financial statements should be read in conjunction with the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022 (the “2022 Annual Report”) filed with the Securities and Exchange Commission (the “SEC”) on March 9, 2023.
 
There have been no changes to the significant accounting policies described in the 2022 Annual Report that have had a material impact on the unaudited interim consolidated financial statements and related notes, except as mentioned below (see also Note 2e).

 

  c. Use of estimates:
 
The preparation of interim consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the interim consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
 
Significant items subject to such estimates and assumptions include inventory reserves, warranty provision, valuation allowance for deferred tax assets, share-based compensation, fair value of warrants liability and useful lives of property, plant, and equipment. The Company bases these estimates on historical and anticipated results, trends and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.
 
  d.
Concentration of credit risk:
 
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, trade receivables, marketable securities, bank deposits, restricted deposits and restricted cash.
 
Trade receivable of the Company are mainly derived from customers located globally. The Company mitigates its credit risks by performing credit evaluations of its customers’ financial conditions and requires customer advance payments in certain circumstances. The Company generally does not require collateral.
 
The Company invests in marketable securities with an average credit rating of “A” and a maturity of up to three years. The Company’s investment policy is not to invest more than 5% of its investment portfolio in a single security at time of purchase.
 
  e.
Recently adopted accounting pronouncement:
 
On January 1, 2023, the Company adopted ASU No. 2016-13 (Topic 326), Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments, which has replaced the previous incurred loss impairment methodology. Under the new guidance an entity is required to recognize an allowance that reflects its current estimate of credit losses expected to be incurred over the life of the financial instrument based on historical experience, current conditions and reasonable and supportable forecasts. The adoption of ASU 2016-13 did not have a material impact on the interim consolidated financial statements.
 
v3.23.2
CONTRACT BALANCES AND REMAINING PERFORMANCE OBLIGATIONS
6 Months Ended
Jun. 30, 2023
Revenue from Contract with Customer [Abstract]  
CONTRACT BALANCES AND REMAINING PERFORMANCE OBLIGATIONS

NOTE 3:-

CONTRACT BALANCES AND REMAINING PERFORMANCE OBLIGATIONS

 
Contract liabilities consisted of the following as of June 30, 2023 and December 31, 2022:
 
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
(Unaudited)
       
Contract liabilities, Current
           
Deferred revenues
 
$
4,151
   
$
4,004
 
Advances from customers
   
68
     
78
 
Total
 
$
4,219
   
$
4,082
 
                 
Contract liabilities, Long-term
               
Deferred revenues
 
$
121
   
$
61
 
Total Contract liabilities
 
$
4,340
   
$
4,143
 
 
During the six months ended June 30, 2023, the Company recognized $42 that was included in deferred revenues balance at December 31, 2022.
 
Remaining Performance Obligation
 
The Company’s remaining performance obligations are comprised of product and engineering services not yet satisfied. As of June 30, 2023, the aggregate amount of the transaction price allocated to remaining performance obligations was $12,536 (out of which, $3,441 is recorded as short-term deferred revenues), which the Company expects to recognize as revenues.
 
v3.23.2
FAIR VALUE MEASUREMENTS
6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS

NOTE 4:-

FAIR VALUE MEASUREMENTS

 
The below table sets forth the Company’s assets and liabilities that were measured at fair value as of June 30, 2023 and December 31, 2022 by level within the fair value hierarchy.
 
June 30, 2023
 
(Unaudited)
 
 
 
Level 1
   
Level 2
   
Level 3
   
Total
 
Assets:
                       
Marketable securities
 
$
-
   
$
32,477
   
$
-
   
$
32,477
 
 
                               
Total financial assets
 
$
-
   
$
32,477
   
$
-
   
$
32,477
 
                                 
Liabilities:
                               
Warrants (1)
 
$
-
   
$
-
   
$
467
   
$
467
 
                                 
Total financial liabilities
 
$
-
   
$
-
   
$
467
   
$
467
 
 
December 31, 2022
 
 
 
Level 1
   
Level 2
   
Level 3
   
Total
 
Assets:
                       
Marketable securities
 
$
-
   
$
49,521
   
$
-
   
$
49,521
 
 
                               
Total financial assets
 
$
-
   
$
49,521
   
$
-
   
$
49,521
 
                                 
Liabilities:
                               
Warrants (1)
 
$
-
   
$
-
   
$
720
   
$
720
 
                                 
Total financial liabilities
 
$
-
   
$
-
   
$
720
   
$
720
 
 
During the six months ended June 30, 2023, the Company recognized net trading gain of $237 which relates to marketable securities held by the Company.
 
  (1)
As part of the Transactions (see Note 1c), the Company assumed a derivative warrants liability related to previously issued private placement warrants in connection with Collective Growth’s initial public offering. The Company utilizes a Black-Scholes option pricing model to estimate the fair value of the private placement warrants which is considered a Level 3 fair value measurement. The warrants are measured at each reporting period, with changes in fair value recognized in financing income, net.
 
The change in the fair value of the derivative private warrants liability is summarized as follows:
 
   
Six Months Ended June 30,
 
   
2023
   
2022
 
   
(Unaudited)
 
Balance as of January 1
 
$
720
   
$
1,639
 
Change in fair value of warrants liability
   
(245
)
   
(789
)
Reclassification of warrants liability to equity
   
(8
)
   
(15
)
Balance as of June 30
 
$
467
   
$
835
 
 
The estimated fair value of the private placement warrant derivative liabilities is determined using Level 3 inputs. Inherent in a Black-Scholes option pricing model are assumptions related to expected share price volatility, expiration, risk-free interest rate and dividend yield. The Company estimates the volatility of its private warrants based on implied volatility of the publicly traded warrants and the historical volatility of the company’s share price and of a selected peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve as of the valuation date for a maturity similar to the expiration of the warrants. The dividend yield is based on the historical rate, which the Company anticipates remaining at zero. The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:
 
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
(Unaudited)
       
Fair value determined per warrant
 
$
1.03
   
$
1.57
 
Expected volatility
   
105
%
   
92.5
%
Expected annual dividend yield
   
0
%
   
0
%
Expected term (years)
   
2.8
     
3.3
 
Risk-free rate
   
4.6
%
   
4.2
%
v3.23.2
LEASES
6 Months Ended
Jun. 30, 2023
Leases [Abstract]  
LEASES

NOTE 5:-

LEASES

 
Below is a summary of the Company operating right-of-use assets, net and operating lease liabilities as of June 30, 2023:
 
Operating lease right-of-use assets, net
 
$
26,528
 
 
       
Operating lease liabilities, current
 
$
5,602
 
Operating lease liabilities, non-current
   
28,122
 
 
       
Total operating lease liabilities
 
$
33,724
 
Weighted average remaining lease term (years)
   
9.37
 
Weighted average discount rate of operating leases
   
4.59
%

 

Additional information regarding the Company’s operating leases:
 
   
Six Months Ended
June 30, 2023
(unaudited)
 
Operating lease costs
 
$
1,894
 
Variable lease payments
 
$
118
 
Short term lease costs
 
$
6
 
Operating cash flows from lease incentives received, net of cash paid for operating leases
 
$
184
 
 
Minimum lease payments over the remaining lease periods as of June 30, 2023, are as follows:
 
Year Ended December 31, (unaudited)
     
2023
 
$
1,997
 
2024
   
3,876
 
2025
   
4,204
 
2026
   
4,207
 
2027
   
4,197
 
Thereafter
   
20,750
 
 
       
Total undiscounted lease payments
 
$
39,231
 
 
       
Less: interest
   
(5,507
)
 
       
Present value of lease liabilities
 
$
33,724
 
v3.23.2
COMMITMENTS AND CONTINGENCIES
6 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES
NOTE 6:-
COMMITMENTS AND CONTINGENCIES
 
Legal proceedings:
 
The Company is currently not part, as plaintiff or defendant, to any legal proceedings that, individually or in the aggregate, are expected by the Company to have a material effect on the Company's business, financial position, results of operations or cash flows. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss. These accruals are reviewed at least yearly and adjusted to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a matter.

 

v3.23.2
SHARE-BASED COMPENSATION
6 Months Ended
Jun. 30, 2023
Share-based Payment Arrangement [Abstract]  
SHARE-BASED COMPENSATION
NOTE 7:-
SHARE-BASED COMPENSATION
 
  a.
Options granted:
 
A summary of option balances as of June 30, 2023 (unaudited), and changes during the six months then ended are as follows:
 
   
Number of options
   
Weighted-average exercise price
   
Weighted- average
remaining contractual term 
(in years)
   
Aggregate intrinsic value
 
                         
Outstanding as of December 31, 2022
   
14,080,996
   
$
5.24
     
6.00
   
$
19,724
 
                                 
Granted
   
11,784
    $
4.75
             
-
 
Exercised
   
(289,851
)
  $
0.80
            $
786
 
Forfeited
   
(191,460
)
  $
5.36
            $
114
 
Expired
   
(67,235
)
  $
7.66
             
-
 
                                 
Outstanding as of June 30, 2023
   
13,544,234
   
$
5.33
     
5.45
   
$
12,079
 
                                 
Exercisable as of June 30, 2023
   
9,954,056
   
$
5.20
     
5.33
   
$
10,692
 
 
  b.
RSUs granted:
 
A summary of RSUs activity for the six months ended June 30, 2023 (unaudited), is as follows:
 
   
Number of
shares
   
Weighted
average grant date fair value
per share
 
             
Unvested as of December 31, 2022
   
7,308,579
   
$
5.95
 
Granted
   
960,622
   

$

4.06
 
Vested
   
(661,280
)
 

$

5.99
 
Forfeited
   
(285,596
)
 

$

5.43
 
Unvested as of June 30, 2023
   
7,322,325
   
$
5.72
 
 
  c.
Share-based compensation expenses:
 
The total share-based compensation expenses related to all of the Company’s equity-based awards, which include options and RSUs recognized in the Company’s consolidated statements of operations for the six months ended June 30, 2023, and 2022, are as follows:
 
   
Six Months Ended June 30,
 
   
2023
   
2022
 
   
(Unaudited)
 
Cost of revenues
 
$
181
   
$
76
 
Research and development
   
6,926
     
5,380
 
Sales and marketing
   
682
     
1,367
 
General and administrative
   
2,654
     
2,342
 
   
$
10,443
   
$
9,165
 
 
As of June 30, 2023, unrecognized compensation cost related to share options and RSUs was $42,363, which is expected to be recognized over a weighted average period of 2.55 years.
v3.23.2
BASIC AND DILUTED NET LOSS PER SHARE
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
BASIC AND DILUTED NET LOSS PER SHARE
NOTE 8:-
BASIC AND DILUTED NET LOSS PER SHARE
 
The following table sets forth the computation of the net loss per share for the period presented:
 
   
Six Months Ended June 30,
 
   
2023
   
2022
 
   
(Unaudited)
 
             
Numerator:
           
             
Net Loss
 
$
(65,974
)
 
$
(58,346
)
                 
Denominator:
               
 
               
     
136,640,997
     
134,607,839
 
 
The following potential ordinary shares have been excluded from the calculation of diluted net loss per share for the period presented due to their anti-dilutive effect:
 
  a.
16,231,141 warrants, 2,402,178 sponsors earnout shares, 20,866,559 outstanding options to purchase Ordinary Shares and unvested RSUs as of June 30, 2023.
 
  b.
16,231,141 warrants, 2,402,178 sponsors earnout shares, 20,096,766 outstanding options to purchase Ordinary Shares and unvested RSUs as of June 30, 2022.
v3.23.2
GEOGRAPHIC AND CUSTOMER INFORMATION
6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
GEOGRAPHIC AND CUSTOMER INFORMATION

NOTE 9:-

GEOGRAPHIC AND CUSTOMER INFORMATION

 

  a.
Geographic information:
 
Following is a summary of revenues by geographic areas. Revenues attributed to geographic areas, based on the location where the customers accept delivery of the products and services:
 
   
Six Months Ended June 30,
 
   
2023
   
2022
 
   
(Unaudited)
 
             
Europe, Middle East and Africa (*)
 
$
1,640
   
$
2,000
 
Asia Pacific
   
260
     
334
 
North America (**)
   
576
     
1,237
 
                 
   
$
2,476
   
$
3,571
 
 
  (*)
Includes revenue from Germany in the amount of $1,500 thousand and $1,926 thousand for the six months ended June 30, 2023 and 2022, respectively.
 
  (**)
Includes revenues from United States only.
 
  b.
Customers accounted for over 10% of revenue:
 
As of June 30, 2023, Customer A, B and C accounted for 41%, 23%, 16% of revenues, respectively.
 
As of June 30, 2022, Customer B accounted for 81% of revenues.
v3.23.2
SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Interim Financial Statements
  a.
Interim Financial Statements
 
The accompanying interim consolidated balance sheet as of June 30, 2023, the interim consolidated statements of operations and the interim consolidated statements of cash flows for the six months ended June 30, 2023 and 2022, as well as the interim statement of changes in shareholders’ equity for the six months ended June 30, 2023 and 2022, are unaudited. These unaudited interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission regarding interim financial reporting. In management’s opinion, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for the fair presentation of the Company’s financial position as of June 30, 2023, as well as its results of operations and cash flows for the six months ended June 30, 2023 and 2022. The results of operations for the six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for other interim periods or for future years.
Significant accounting policies
  b.
Significant accounting policies
 
The accompanying unaudited interim financial statements should be read in conjunction with the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022 (the “2022 Annual Report”) filed with the Securities and Exchange Commission (the “SEC”) on March 9, 2023.
 
There have been no changes to the significant accounting policies described in the 2022 Annual Report that have had a material impact on the unaudited interim consolidated financial statements and related notes, except as mentioned below (see also Note 2e).

 

Use of estimates
  c. Use of estimates:
 
The preparation of interim consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the interim consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
 
Significant items subject to such estimates and assumptions include inventory reserves, warranty provision, valuation allowance for deferred tax assets, share-based compensation, fair value of warrants liability and useful lives of property, plant, and equipment. The Company bases these estimates on historical and anticipated results, trends and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.
Concentration of credit risk
  d.
Concentration of credit risk:
 
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, trade receivables, marketable securities, bank deposits, restricted deposits and restricted cash.
 
Trade receivable of the Company are mainly derived from customers located globally. The Company mitigates its credit risks by performing credit evaluations of its customers’ financial conditions and requires customer advance payments in certain circumstances. The Company generally does not require collateral.
 
The Company invests in marketable securities with an average credit rating of “A” and a maturity of up to three years. The Company’s investment policy is not to invest more than 5% of its investment portfolio in a single security at time of purchase.
Recently adopted accounting pronouncement
  e.
Recently adopted accounting pronouncement:
 
On January 1, 2023, the Company adopted ASU No. 2016-13 (Topic 326), Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments, which has replaced the previous incurred loss impairment methodology. Under the new guidance an entity is required to recognize an allowance that reflects its current estimate of credit losses expected to be incurred over the life of the financial instrument based on historical experience, current conditions and reasonable and supportable forecasts. The adoption of ASU 2016-13 did not have a material impact on the interim consolidated financial statements.
 
v3.23.2
CONTRACT BALANCES AND REMAINING PERFORMANCE OBLIGATIONS (Tables)
6 Months Ended
Jun. 30, 2023
Revenue from Contract with Customer [Abstract]  
Summary of contract liabilities
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
(Unaudited)
       
Contract liabilities, Current
           
Deferred revenues
 
$
4,151
   
$
4,004
 
Advances from customers
   
68
     
78
 
Total
 
$
4,219
   
$
4,082
 
                 
Contract liabilities, Long-term
               
Deferred revenues
 
$
121
   
$
61
 
Total Contract liabilities
 
$
4,340
   
$
4,143
 
v3.23.2
FAIR VALUE MEASUREMENTS (Tables)
6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
Summary of assets and liabilities at fair value on a recurring basis
June 30, 2023
 
(Unaudited)
 
 
 
Level 1
   
Level 2
   
Level 3
   
Total
 
Assets:
                       
Marketable securities
 
$
-
   
$
32,477
   
$
-
   
$
32,477
 
 
                               
Total financial assets
 
$
-
   
$
32,477
   
$
-
   
$
32,477
 
                                 
Liabilities:
                               
Warrants (1)
 
$
-
   
$
-
   
$
467
   
$
467
 
                                 
Total financial liabilities
 
$
-
   
$
-
   
$
467
   
$
467
 
 
December 31, 2022
 
 
 
Level 1
   
Level 2
   
Level 3
   
Total
 
Assets:
                       
Marketable securities
 
$
-
   
$
49,521
   
$
-
   
$
49,521
 
 
                               
Total financial assets
 
$
-
   
$
49,521
   
$
-
   
$
49,521
 
                                 
Liabilities:
                               
Warrants (1)
 
$
-
   
$
-
   
$
720
   
$
720
 
                                 
Total financial liabilities
 
$
-
   
$
-
   
$
720
   
$
720
 
  (1)
As part of the Transactions (see Note 1c), the Company assumed a derivative warrants liability related to previously issued private placement warrants in connection with Collective Growth’s initial public offering. The Company utilizes a Black-Scholes option pricing model to estimate the fair value of the private placement warrants which is considered a Level 3 fair value measurement. The warrants are measured at each reporting period, with changes in fair value recognized in financing income, net.
Summary of the binomial (lattice) valuation model assumptions used to record the fair value of the warrants
   
Six Months Ended June 30,
 
   
2023
   
2022
 
   
(Unaudited)
 
Balance as of January 1
 
$
720
   
$
1,639
 
Change in fair value of warrants liability
   
(245
)
   
(789
)
Reclassification of warrants liability to equity
   
(8
)
   
(15
)
Balance as of June 30
 
$
467
   
$
835
 
Summary of change in the level 3 warrant liability
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
(Unaudited)
       
Fair value determined per warrant
 
$
1.03
   
$
1.57
 
Expected volatility
   
105
%
   
92.5
%
Expected annual dividend yield
   
0
%
   
0
%
Expected term (years)
   
2.8
     
3.3
 
Risk-free rate
   
4.6
%
   
4.2
%
v3.23.2
LEASES (Tables)
6 Months Ended
Jun. 30, 2023
Leases [Abstract]  
Summary of operating right-of-use assets and operating lease liabilities
 
Operating lease right-of-use assets, net
 
$
26,528
 
 
       
Operating lease liabilities, current
 
$
5,602
 
Operating lease liabilities, non-current
   
28,122
 
 
       
Total operating lease liabilities
 
$
33,724
 
Weighted average remaining lease term (years)
   
9.37
 
Weighted average discount rate of operating leases
   
4.59
%
Summary of operating lease costs
 
   
Six Months Ended
June 30, 2023
(unaudited)
 
Operating lease costs
 
$
1,894
 
Variable lease payments
 
$
118
 
Short term lease costs
 
$
6
 
Operating cash flows from lease incentives received, net of cash paid for operating leases
 
$
184
 
Summary of minimum lease payments over the remaining lease
 
Year Ended December 31, (unaudited)
     
2023
 
$
1,997
 
2024
   
3,876
 
2025
   
4,204
 
2026
   
4,207
 
2027
   
4,197
 
Thereafter
   
20,750
 
 
       
Total undiscounted lease payments
 
$
39,231
 
 
       
Less: interest
   
(5,507
)
 
       
Present value of lease liabilities
 
$
33,724
 
v3.23.2
SHARE-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2023
Share-based Payment Arrangement [Abstract]  
Summary of share-based compensation arrangements by share-based payment award
 
   
Number of options
   
Weighted-average exercise price
   
Weighted- average
remaining contractual term 
(in years)
   
Aggregate intrinsic value
 
                         
Outstanding as of December 31, 2022
   
14,080,996
   
$
5.24
     
6.00
   
$
19,724
 
                                 
Granted
   
11,784
    $
4.75
             
-
 
Exercised
   
(289,851
)
  $
0.80
            $
786
 
Forfeited
   
(191,460
)
  $
5.36
            $
114
 
Expired
   
(67,235
)
  $
7.66
             
-
 
                                 
Outstanding as of June 30, 2023
   
13,544,234
   
$
5.33
     
5.45
   
$
12,079
 
                                 
Exercisable as of June 30, 2023
   
9,954,056
   
$
5.20
     
5.33
   
$
10,692
 
Summary of restricted stock units granted
   
Number of
shares
   
Weighted
average grant date fair value
per share
 
             
Unvested as of December 31, 2022
   
7,308,579
   
$
5.95
 
Granted
   
960,622
   

$

4.06
 
Vested
   
(661,280
)
 

$

5.99
 
Forfeited
   
(285,596
)
 

$

5.43
 
Unvested as of June 30, 2023
   
7,322,325
   
$
5.72
 
Summary of share-based payment arrangement, expensed and capitalized, amount
   
Six Months Ended June 30,
 
   
2023
   
2022
 
   
(Unaudited)
 
Cost of revenues
 
$
181
   
$
76
 
Research and development
   
6,926
     
5,380
 
Sales and marketing
   
682
     
1,367
 
General and administrative
   
2,654
     
2,342
 
   
$
10,443
   
$
9,165
 
v3.23.2
BASIC AND DILUTED NET LOSS PER SHARE (Tables)
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Summary of computation of the net loss per share
 
   
Six Months Ended June 30,
 
   
2023
   
2022
 
   
(Unaudited)
 
             
Numerator:
           
             
Net Loss
 
$
(65,974
)
 
$
(58,346
)
                 
Denominator:
               
 
               
     
136,640,997
     
134,607,839
 
v3.23.2
GEOGRAPHIC AND CUSTOMER INFORMATION (Tables)
6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Summary of reportable segments
 
   
Six Months Ended June 30,
 
   
2023
   
2022
 
   
(Unaudited)
 
             
Europe, Middle East and Africa (*)
 
$
1,640
   
$
2,000
 
Asia Pacific
   
260
     
334
 
North America (**)
   
576
     
1,237
 
                 
   
$
2,476
   
$
3,571
 
 
  (*)
Includes revenue from Germany in the amount of $1,500 thousand and $1,926 thousand for the six months ended June 30, 2023 and 2022, respectively.
 
  (**)
Includes revenues from United States only.
v3.23.2
GENERAL (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Cash and cash equivalents $ 34,331 $ 55,718 $ 50,279
Bank deposits 62,710 $ 80,684  
Total financial assets $ 32,477    
v3.23.2
SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Line Items]  
Percentage of investment portfolio not to invest more in single security 5.00%
v3.23.2
CONTRACT BALANCES AND REMAINING PERFORMANCE OBLIGATIONS - Summary of Contract Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Contract liabilities, Current    
Deferred revenues $ 4,151 $ 4,004
Advances from customers 68 78
Total 4,219 4,082
Contract liabilities, Long-term    
Deferred revenues 121 61
Total Contract liabilities $ 4,340 $ 4,143
v3.23.2
CONTRACT BALANCES AND REMAINING PERFORMANCE OBLIGATIONS - Additional Information (Details)
$ in Thousands
6 Months Ended
Jun. 30, 2023
USD ($)
Revenue from Contract with Customer [Abstract]  
Contract with customers liability recognized $ 42
Performance obligations transaction price 12,536
Performance obligations transaction price recorded as short-term deferred revenues $ 3,441
v3.23.2
FAIR VALUE MEASUREMENTS - Summary Of Assets And Liabilities At Fair Value On a Recurring Basis (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Assets, Fair Value Disclosure [Abstract]    
Total financial assets $ 32,477  
Fair Value, Recurring [Member]    
Assets, Fair Value Disclosure [Abstract]    
Total financial assets 32,477 $ 49,521
Liabilities:    
Total financial liabilities 467 720
Fair Value, Recurring [Member] | Warrant [Member]    
Liabilities:    
Warrant liability [1] 467 720
Fair Value, Recurring [Member] | Marketable securities [Member]    
Assets, Fair Value Disclosure [Abstract]    
Marketable securities 32,477 49,521
Level 1 [Member] | Fair Value, Recurring [Member]    
Assets, Fair Value Disclosure [Abstract]    
Total financial assets 0 0
Liabilities:    
Total financial liabilities 0 0
Level 1 [Member] | Fair Value, Recurring [Member] | Warrant [Member]    
Liabilities:    
Warrant liability [1] 0 0
Level 1 [Member] | Fair Value, Recurring [Member] | Marketable securities [Member]    
Assets, Fair Value Disclosure [Abstract]    
Marketable securities 0 0
Level 2 [Member] | Fair Value, Recurring [Member]    
Assets, Fair Value Disclosure [Abstract]    
Total financial assets 32,477 49,521
Liabilities:    
Total financial liabilities 0 0
Level 2 [Member] | Fair Value, Recurring [Member] | Warrant [Member]    
Liabilities:    
Warrant liability [1] 0 0
Level 2 [Member] | Fair Value, Recurring [Member] | Marketable securities [Member]    
Assets, Fair Value Disclosure [Abstract]    
Marketable securities 32,477 49,521
Level 3 [Member] | Fair Value, Recurring [Member]    
Assets, Fair Value Disclosure [Abstract]    
Total financial assets 0 0
Liabilities:    
Total financial liabilities 467 720
Level 3 [Member] | Fair Value, Recurring [Member] | Warrant [Member]    
Liabilities:    
Warrant liability [1] 467 720
Level 3 [Member] | Fair Value, Recurring [Member] | Marketable securities [Member]    
Assets, Fair Value Disclosure [Abstract]    
Marketable securities $ 0 $ 0
[1] As part of the Transactions (see Note 1c), the Company assumed a derivative warrants liability related to previously issued private placement warrants in connection with Collective Growth’s initial public offering. The Company utilizes a Black-Scholes option pricing model to estimate the fair value of the private placement warrants which is considered a Level 3 fair value measurement. The warrants are measured at each reporting period, with changes in fair value recognized in financing income, net.
v3.23.2
FAIR VALUE MEASUREMENTS - Summary Of Change In The Level 3 Warrant Liability (Details) - Warrant [Member] - Level 3 [Member] - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance $ 720 $ 1,639
Change in fair value of warrants liability (245) (789)
Reclassification of warrants liability to equity (8) (15)
Balance $ 467 $ 835
v3.23.2
FAIR VALUE MEASUREMENTS - Summary Of Binomial (Lattice) Valuation Model Assumptions Used To Record The Fair Value Of The Warrants (Details) - Level 3 [Member] - Warrant [Member] - $ / shares
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair vale determined per warrant $ 1.03 $ 1.57
Expected volatility 105.00% 92.50%
Expected annual dividend yield 0.00% 0.00%
Expected term (years) 2 years 9 months 18 days 3 years 3 months 18 days
Risk-free rate 4.60% 4.20%
v3.23.2
FAIR VALUE MEASUREMENTS - Additional Information (Details)
$ in Thousands
6 Months Ended
Jun. 30, 2023
USD ($)
Fair Value Disclosures [Abstract]  
Gain relates to marketable securities held $ 237
v3.23.2
LEASES - Summary of Operating Right-of-Use Assets and Operating Lease Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Leases [Abstract]    
Operating lease right-of-use assets, net $ 26,528 $ 26,927
Operating lease liabilities, current 5,602 3,720
Operating lease liabilities, non-current 28,122 $ 30,201
Total operating lease liabilities $ 33,724  
Weighted average remaining lease term (years) 9 years 4 months 13 days  
Weighted average discount rate of operating leases 4.59%  
v3.23.2
LEASES - Summary of Operating Lease Costs (Details)
$ in Thousands
6 Months Ended
Jun. 30, 2023
USD ($)
Leases [Abstract]  
Operating lease costs $ 1,894
Variable lease payments 118
Short term lease costs 6
Operating cash flows from lease incentives received, net of cash paid for operating leases $ 184
v3.23.2
LEASES - Summary of Minimum Operating Lease Payments (Details)
$ in Thousands
Jun. 30, 2023
USD ($)
Leases [Abstract]  
2023 $ 1,997
2024 3,876
2025 4,204
2026 4,207
2027 4,197
Thereafter 20,750
Total undiscounted lease payments 39,231
Less: interest (5,507)
Present value of lease liabilities $ 33,724
v3.23.2
SHARE-BASED COMPENSATION - Summary of Share-Based Compensation Arrangements by Share-based Payment Award (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Share-based Payment Arrangement [Abstract]    
Number of options Outstanding 14,080,996  
Number of options Granted 11,784  
Number of options Exercised (289,851)  
Number of options Forfeited (191,460)  
Number of options Expired (67,235)  
Number of options Outstanding at End 13,544,234 14,080,996
Number of options Exercisable 9,954,056  
Weighted- average exercise price,Outstanding $ 5.24  
Weighted- average exercise price Granted 4.75  
Weighted- average exercise price Exercised 0.8  
Weighted- average exercise price Forfeited 5.36  
Weighted- average exercise price Expired 7.66  
Weighted- average exercise price Outstanding at end 5.33 $ 5.24
Weighted- average exercise price Exercisable $ 5.2  
Weighted- average remaining contractual term Outstanding at end 5 years 5 months 12 days 6 years
Weighted- average remaining contractual term Exercisable 5 years 3 months 29 days  
Aggregate intrinsic value, Outstanding $ 19,724  
Aggregate intrinsic value, Granted 0  
Aggregate intrinsic value, Exercised 786  
Aggregate intrinsic value, Forfeited 114  
Aggregate intrinsic value, Expired 0  
Aggregate intrinsic value, Outstanding at end 12,079 $ 19,724
Aggregate intrinsic value Exercisable $ 10,692  
v3.23.2
SHARE-BASED COMPENSATION - Summary of Restricted Stock Unit's activity (Details) - RSUs
6 Months Ended
Jun. 30, 2023
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unvested as of December 31, 2022 | shares 7,308,579
Granted | shares 960,622
Vested | shares (661,280)
Forfeited | shares (285,596)
Unvested as of June 30, 2023 | shares 7,322,325
Weighted average grant date fair value per share, Unvested as of December 31, 2022 | $ / shares $ 5.95
Weighted average grant date fair value per share, Granted | $ / shares 4.06
Weighted average grant date fair value per share, Vested | $ / shares 5.99
Weighted average grant date fair value per share, Forfeited | $ / shares 5.43
Weighted average grant date fair value per share, Unvested as of June 30, 2023 | $ / shares $ 5.72
v3.23.2
SHARE-BASED COMPENSATION - Summary of Share-Based Payment Arrangement, Expensed and Capitalized, Amount (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Share-based payment arrangement, expense $ 10,443 $ 9,165
Cost of revenues [Member]    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Share-based payment arrangement, expense 181 76
Research and development [Member]    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Share-based payment arrangement, expense 6,926 5,380
Sales and marketing [Member]    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Share-based payment arrangement, expense 682 1,367
General and administrative [Member]    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Share-based payment arrangement, expense $ 2,654 $ 2,342
v3.23.2
SHARE-BASED COMPENSATION - Additional Information (Details)
$ in Thousands
6 Months Ended
Jun. 30, 2023
USD ($)
Share-based Payment Arrangement [Abstract]  
Share based compensation by share based payment arrangement options unrecognized compensation $ 42,363
Share based compensation by share based payment arrangement weighted average period of recognition 2 years 6 months 18 days
v3.23.2
BASIC AND DILUTED NET LOSS PER SHARE - Summary of Computation of the Net Loss Per Share (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Numerator:    
Net loss $ (65,974) $ (58,346)
Denominator:    
Weighted average number of ordinary shares used in computing basic net loss per ordinary share 136,640,997 134,607,839
v3.23.2
BASIC AND DILUTED NET LOSS PER SHARE - Additional Information (Details) - Options For Purchase Of Ordinary Shares [Member] - shares
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Warrant [Member]    
Earnings Per Share [Line Items]    
Anti dilutive securities excluded in calculation of earnings per share 16,231,141 16,231,141
Sponsors earnout shares [Member]    
Earnings Per Share [Line Items]    
Anti dilutive securities excluded in calculation of earnings per share 2,402,178 2,402,178
Options and RSUs outstanding [Member]    
Earnings Per Share [Line Items]    
Anti dilutive securities excluded in calculation of earnings per share 20,866,559 20,096,766
v3.23.2
GEOGRAPHIC AND CUSTOMER INFORMATION - Summary of Reportable Segments (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Segment Reporting Information [Line Items]    
Revenue from Contract with Customer, Excluding Assessed Tax $ 2,476 $ 3,571
Europe Middle East And Africa [Member]    
Segment Reporting Information [Line Items]    
Revenue from Contract with Customer, Excluding Assessed Tax [1] 1,640 2,000
Asia Pacific [Member]    
Segment Reporting Information [Line Items]    
Revenue from Contract with Customer, Excluding Assessed Tax 260 334
North America [Member]    
Segment Reporting Information [Line Items]    
Revenue from Contract with Customer, Excluding Assessed Tax [2] $ 576 $ 1,237
[1] Includes revenue from Germany in the amount of $1,500 thousand and $1,926 thousand for the six months ended June 30, 2023 and 2022, respectively.
[2] Includes revenues from United States only.
v3.23.2
GEOGRAPHIC AND CUSTOMER INFORMATION - Summary of Reportable Segments (Parenthetical) (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Segment Reporting Information [Line Items]    
Revenues $ 2,476 $ 3,571
Germany [Member]    
Segment Reporting Information [Line Items]    
Revenues $ 1,500 $ 1,926
v3.23.2
GEOGRAPHIC AND CUSTOMER INFORMATION - Additional Information (Details) - Customer Concentration Risk [Member] - Revenue Benchmark [Member]
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Customer A [Member]    
Segment Reporting Information [Line Items]    
Concentration risk percentage 41.00%  
Customer B [Member]    
Segment Reporting Information [Line Items]    
Concentration risk percentage 23.00% 81.00%
Customer C [Member]    
Segment Reporting Information [Line Items]    
Concentration risk percentage 16.00%  

Innoviz Technologies (NASDAQ:INVZ)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024 Innoviz Technologies 차트를 더 보려면 여기를 클릭.
Innoviz Technologies (NASDAQ:INVZ)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024 Innoviz Technologies 차트를 더 보려면 여기를 클릭.